Advanced glycation end-product cross-link breakers

Overview of attention for article published in American Journal of Hypertension, December 2004

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

wikipedia: 4 Wikipedia pages

Readers on

mendeley: 104 Mendeley

So far, Altmetric has seen 4 citations on 4 Wikipedia pages.

Ukrainian

Стабільні кінцеві продукти глікації

Cited by user Євген Антонов on 24 Feb 2025

Стабільні кінцеві продукти глікації (Advanced glycation end products, AGE) — це білки або ліпіди, які глікуються в результаті впливу цукрів.

Russian

Конечные продукты гликирования

Cited by user Minina on 10 Dec 2019

Serbian

Alagebrijum

Cited by user Dcirovic on 11 Nov 2012

Alagebrijum (-{ALT-711}-) je potencijalni lek. On je bio prvi kandidat leka koji je klinički testiran kao sredstvo za raskidanje umrežavanja uzrokovanog krajnjim…

English

Alagebrium

Cited by user Citation bot on 26 Nov 2010

Alagebrium (formerly known as ALT-711) was a drug candidate developed by Alteon Corporation.

This page shows the most recent Wikipedia articles that mention this research output. Click here to find out how to access more activity.